PTHL: Pheton Holdings Kompaniya qiymatining sof foydaga nisbati

Pheton Holdings (PTHL) korporativ emblemasi va logotipi

Pheton Holdings Ltd (PTHL) Xitoyning biotexnologiya sektorida nufuzli imijni shakllantirmoqda, bu esa tibbiyot doiralari orasida kompaniyaning tadqiqotlariga nisbatan katta qiziqish uyg'otmoqda. Kompaniya braxiterapiya uchun ixtisoslashtirilgan dasturiy ta'minot va materiallar yetkazib beradi, ignalar savdosi hamda klinikalarning uning rejalashtirish tizimlariga bog'lanib qolishi orqali daromad ko'radi. -3.60 metrikasi aks etgan ushbu grafik uning bozordagi pozitsiyalarini tasdiqlaydi. Algoritmik patentlar va yadro tibbiyotidagi qat'iy xavfsizlik standartlari kirish uchun yuqori to'siqlarni yaratadi.

PTHL Pheton Holdings Limited: Narx-foyda koeffitsiyenti 06.09.2024 - 16.01.2026 oraligʻida

Pheton Holdings Limited (PTHL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Pheton Holdings Limited - PTHL
Pheton Holdings yetakchi tovari

Hissiy aktivlar uchun investitsiya ishonchliligini baholash sof foyda nisbatidagi bozor qiymatini tahlil qilishga asoslanadi, bu esa kelajakdagi o'sish uchun to'langan premium miqdorini belgilaydi. Ushbu ko'rsatkich foydani kapitalizatsiya qilish samaradorligini o'lchaydi va Osiyo yetkazib berish zanjirlarini optimallashtirish kontekstida Pheton Holdings Ltd (PTHL) kompaniyasining oylik P/E dinamikasi sotuv xarajatlarining kamayishi va biznes marjalarining yaxshilanishiga oid bozor kutganlarini aks ettiradi.

Raqobatdosh kompaniyalar tahlili

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|HYFT: Narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Narxning foydaga nisbati|cumberlandpharma.com (CPIX) - P/E multiplikatori|QNTM (Quantum BioPharma) - P/E multiplikatori|FGEN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TELO|P/E multiplikatori Rani Therapeutics Holdings (RANI)|P/E multiplikatori SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Kapitalizatsiyaning foydaga nisbati|LEXX - Narxning foydaga nisbati|PULM (Pulmatrix) - Narx-foyda multiplikatori|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)